±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 4894  |  »Ø¸´: 3
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

ÂÞÈýÅÚ

½ð³æ (ÖøÃûдÊÖ)

[ÇóÖú] top-line results ÊÇʲôÒâ˼£¿ ÒÑÓÐ3È˲ÎÓë

ÇóÖú£ºÒÔÏÂÖеÄtop-line results  ÊÇʲôÒâ˼£¿
Pfizer Inc. (NYSEFE) today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer (NSCLC).

http://www.pfizer.com/news/press ... ll_cell_lung_cancer
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

kwindmark

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÂÞÈýÅÚ: ½ð±Ò+6, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£²»´í£¡Ð»Ð»£¡ 2015-04-03 19:20:57
¡°Top-line Results¡± is a statistical term of art.  It is analogous to ¡°Bottom-line Results¡± as a finance term of art.  In other words, Top-line Results are the outcomes of the analyses (e.g., totals, frequencies, distributions or marginals) that are the output of a statistical analysis ¨C whether that analysis is based on preliminary data or final data.  

In the clinical arena, Top-line Results (regardless of the stage of the trial or the phase of the trial) speak to the statistical significance of the trial results coming out of the subject population.  Pharma often cites Top-line Results as the basis for its decision to terminate a trial or to continue a trial.
4Â¥2015-04-03 14:47:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

kdl0721

½ð³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÂÞÈýÅÚ: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú, ·Ç³£¸Ðл£¡ 2015-04-03 19:21:37
Ó¦¸ÃÊÇ¡°¶¥Ïß½á¹û¡±°É¡£
2Â¥2015-04-03 13:20:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

purongzhen

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÂÞÈýÅÚ: ½ð±Ò+2, ¡ï¡ï¡ïºÜÓаïÖú, ·Ç³£¸Ðл£¡ 2015-04-03 19:21:24
primary endpoint
3Â¥2015-04-03 13:53:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 332Çóµ÷¼Á +4 @MZB382400 2026-03-28 4/200 2026-03-28 21:02 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÀí£¬ÊýÒ»Ó¢Ò»285ÇóAÇøµ÷¼Á +8 AZMK 2026-03-25 12/600 2026-03-28 18:15 by AZMK
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§0703×Ü·Ö337Çóµ÷¼Á +5 niko- 2026-03-27 5/250 2026-03-28 14:25 by ÌÆãå¶ù
[¿¼ÑÐ] 329Çóµ÷¼Á +6 ÐÇÒ°? 2026-03-26 6/300 2026-03-28 14:14 by ÌÆãå¶ù
[¿¼ÑÐ] 0703»¯Ñ§ +10 ÄÝÄÝninicgb 2026-03-27 10/500 2026-03-28 14:07 by ßÕßÕßÕßÉßÉßÉ
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ²ÄÁÏѧ˶Çóµ÷¼Á +3 @taotao 2026-03-28 3/150 2026-03-28 10:26 by JourneyLucky
[¿¼ÑÐ] 308Çóµ÷¼Á +7 īīĮ 2026-03-27 7/350 2026-03-28 07:43 by ÈÈÇéɳĮ
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó×Ü·Ö298·Ö£¬Ç°Èý¿Æ223·Ö +5 dongfang59 2026-03-27 5/250 2026-03-28 04:53 by wxiongid
[¿¼ÑÐ] Çóµ÷¼Á +8 ÕÅzz111 2026-03-27 9/450 2026-03-28 03:41 by fmesaito
[¿¼ÑÐ] »¯Ñ§µ÷¼Á +4 °®³Ô·¬ÇѵÄÐñ 2026-03-24 5/250 2026-03-27 17:50 by kiokin
[¿¼ÑÐ] ¿¼Ñе÷¼Á +4 Sanmu-124 2026-03-26 4/200 2026-03-27 17:49 by kiokin
[¿¼ÑÐ] 307Çóµ÷¼Á +8 ³¬¼¶ÒÁ°º´óÍõ 2026-03-24 9/450 2026-03-27 15:34 by ³¬¼¶ÒÁ°º´óÍõ
[¿¼ÑÐ] 312Çóµ÷¼Á +9 Éϰ¶°ÉZJY 2026-03-22 13/650 2026-03-27 11:24 by sanrepian
[¿¼ÑÐ] 0703»¯Ñ§Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ303Çóµ÷¼Á +3 zzffylgg 2026-03-24 3/150 2026-03-27 10:42 by shangxh
[¿¼ÑÐ] Çóµ÷¼Á +8 Auroracx 2026-03-22 8/400 2026-03-26 19:55 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-25 3/150 2026-03-25 19:03 by Ainin_
[¿¼ÑÐ] 296Çóµ÷¼Á +4 Íô£¡£¿£¡ 2026-03-25 7/350 2026-03-25 16:41 by Íô£¡£¿£¡
[¿¼ÑÐ] ¸÷λÀÏʦÄúºÃ£º±¾È˳õÊÔ372·Ö +5 jjÓ¿77 2026-03-25 6/300 2026-03-25 14:15 by mapenggao
[¿¼ÑÐ] ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£© +4 ÎÒ°®Ñ§µç³Ø 2026-03-23 4/200 2026-03-25 00:59 by 1027_324
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ¶ì¶ì¶ì¶î¶î¶î¶î¶ 2026-03-24 4/200 2026-03-24 16:41 by peike
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û